We are live on ! Find out more

Intuitive Surgical

ISRG

Market cap $150B

423.96 USD

+8.55

2.06%

At close Updated Oct 9, 4:00 PM EDT

Pre-market

After hours

423.80

-0.16

0.04%

1 day

2.06%

5 days

8.77%

1 month

20.02%

3 months

3.02%

6 months

-6.81%

Year to date

-24.56%

1 year

-4.46%

5 years

30.78%

10 years

426.59%

About: Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 11,000 da Vinci systems in hospitals worldwide, with more than 6,600 installations in the US and a growing number in emerging markets.

Employees: 17,021

Healthcare Medical Instruments & Supplies

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 50%

Neutral 28.3%

Negative 21.7%

Zacks Investment Research

Intuitive Surgical, Inc. (ISRG) Exceeds Market Returns: Some Facts to Consider

Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $423.96, signifying a +2.06% move from its prior day's close.

Intuitive Surgical, Inc. (ISRG) Exceeds Market Returns: Some Facts to Consider

Zacks Investment Research

Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?

Zacks Investment Research

Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know

Intuitive Surgical, Inc. (ISRG) reached $414.52 at the closing of the latest trading day, reflecting a +2.41% change compared to its last close.

Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know

Zacks Investment Research

Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise?

Intuitive Surgical SP platform is gaining momentum as procedures, utilization and placements rise, with expanding indications and global adoption fueling growth.

Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise?

Zacks Investment Research

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific

Globus Medical, Intuitive Surgical and Thermo Fisher Scientific have been highlighted in this Industry Outlook article.

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific

Intuitive Surgical: The Multiple Fell, The Story Didn't

Intuitive Surgical remains a wide-moat leader in robotic surgery with strong secular tailwinds and high recurring revenue potential. ISRG's installed base and utilization rates offer significant runway for growth, supported by product innovation and expansion into new markets. Despite a compression in valuation multiples, ISRG's forward P/E remains attractive given its historical premium and robust growth prospects.

Intuitive Surgical: The Multiple Fell, The Story Didn't

Zacks Investment Research

3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes

GenAI offers growth opportunities for GMED, ISRG and TMO, but evolving regulations and industry risks are likely to shape adoption.

3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes

The Motley Fool

2 Beaten-Down Stocks Worth Buying and Holding for the Next Decade

Netflix's large ecosystem offers attractive monetization opportunities if it can boost engagement. Despite recent challenges, Intuitive Surgical could capitalize on the underpenetrated robotic surgery market.

2 Beaten-Down Stocks Worth Buying and Holding for the Next Decade

Intuitive Surgical: The 17% Selloff Is A Buy

Intuitive Surgical, Inc. remains a Buy, with strong recurring revenue, robust cash generation, and a market-leading position in robotic surgery despite recent share price weakness. Q3 expectations reflect slower procedure growth and affordability pressures, but ISRG's installed base, da Vinci 5 upgrade cycle, and SP/Ion adoption underpin long-term growth. Margins are expected to peak this year, aided by extended use programs that lower system costs and potentially increase competitive barriers.

Intuitive Surgical: The 17% Selloff Is A Buy

Zacks Investment Research

Can ISRG Offset China Weakness With Expansion in India and Japan?

Intuitive Surgical sees strong growth in India and improving conditions in Japan helping offset China headwinds as international da Vinci procedures rise 20%.

Can ISRG Offset China Weakness With Expansion in India and Japan?

See News Rankings

Price charts implemented using Lightweight Charts™